Diane G. Gerst - 30 Jun 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
30 Jun 2022
Net transactions value
-$76,945
Form type
4
Filing time
05 Jul 2022, 16:06:04 UTC
Previous filing
14 Jun 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $66,760 +3,333 +26% $20.03 16,175 30 Jun 2022 Direct
transaction AMPH Common Stock Options Exercise $36,405 +1,813 +11% $20.08 17,988 30 Jun 2022 Direct
transaction AMPH Common Stock Sale $180,110 -5,146 -29% $35.00 12,842 30 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -3,333 -48% $0.000000 3,626 30 Jun 2022 Common Stock 3,333 $20.03 Direct F2
transaction AMPH Stock Option (right to buy) Options Exercise $0 -1,813 -23% $0.000000 6,190 30 Jun 2022 Common Stock 1,813 $20.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
F2 Shares subject to the option are fully vested and immediately exercisable.